http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102715394-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35a5eef7a51494d7c62b3d0cd7d602f7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-09
filingDate 2012-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9e5d940d6e3c405e6eeb4d7bc4f9d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d987a75ee9f5586b042cc9e364af30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a265100b73f218533553d396f311f62
publicationDate 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102715394-B
titleOfInvention L-carnitine effervescent tablet
abstract The invention discloses an L-carnitine effervescent tablet which comprises the following components in percentage by weight: 4 to 10% of beet red juice powder, 8 to 13% of fructo-oligosaccharide, 5 to 12% of L-carnitine tartrate, 3 to 8% of citric acid, 3 to 10% of sodium bicarbonate, 25 to 40% of sorbitol, 1 to 4% of food flavour, 0.5 to 2% of APM (Aspartame), 5 to 7% of acesulfame potassium, 3 to7% of fumaric acid and 1.5 to 4% of magnesium stearate. The L-carnitine effervescent tablet not only can reinforce endurance, promote tiredness resume, delay aging process and be favorable for baby health, but also can be favorable for health protection of heart and blood vessels, removal of fatty liver and treatment of hemorrhagic shock medically. The intaken fructo-oligosaccharide can promote the rapid appreciation of bifidobacterium species, restrain growth of harmful bacteria in intestinal canal, and helps a human body to maintain a good intestine and stomach environment.
priorityDate 2012-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22245511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453559759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57367812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53315704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452555451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096

Total number of triples: 40.